Arana Therapeutics Limited
News
Yesterday the Australia market stayed on the red for the third consecutive day. Both the Aussie dollar and the S&P 200 Index fell lower on the news of the latest GDP figures. The benchmark S&P/ASX200 index ended down 1.6%, or 52.8 points, at 3166.4, while the All Ordinaries index loses 1.4%, or 45.5 points, at 3125.9.
The Australian stocks closed Friday with little change after falls from early highs. The benchmark S&P/ASX200 index declined one point, or 0.03 per cent, to 3344.5, while the broader All Ordinaries fell half a point, or 0.02 per cent, to 3296.9. With the reporting seasons over, the market focus will return to the economic data and RBA's rate cut decision this week.
Arana Therapeutics Excellence In Biotechnology Investment - Mr John Chiplin, CEO, Arana Therapeutics
Arana Therapeutics Excellence in Biotechnology Investment - Mr John Chiplin, CEO, Arana Therapeutics; Arana Therapeutics (ASX: AAH) present the following audio webcast regarding "Excellence in Biotechnology Investment - Mr John Chiplin, CEO, Arana Therapeutics". You may also download this audio webcast to your computer or portable audio player.
Peptech (ASX: PTD) - Shareholders Approve Peptech-Evogenix Merger - Dr John Chiplin, CEO; Peptech (ASX: PTD) present the following audio webcast regarding "Shareholders Approve Peptech-Evogenix Merger". You may also download this audio webcast to your computer or portable audio player.
Peptech (ASX: PTD) - Peptech presentation to eG Capital Forum - Dr John Chiplin, CEO; Peptech (ASX: PTD) present the following audio webcast regarding "Peptech presentation to eG Capital Forum".
Peptech (ASX: PTD) - Merger Roadshow Presentation - Dr John Chiplin, MD; Dr Phil Jennings, Exec.
Peptech (ASX: PTD) - Enters Phase I Clinical Trials - Dr Phil Jennings, Executive Director; Boardroomradio is pleased to announce that Peptech (ASX: PTD) has published an audio file.
Peptech (ASX: PTD) - Record Profit for Half Year - Dr John Chiplin, MD; Boardroomradio is pleased to announce that Peptech (ASX: PTD) has published an audio file.
Peptech (ASX: PTD) - Peptech & EvoGenix Merge to Form Antibody Powerhouse - Dr John Chiplin and Dr Merilyn Sleigh; Boardroomradio is pleased to announce that Peptech (ASX: PTD) has published an audio file.
Peptech (ASX: PTD) - Suprelorin Recommendation Clears Path for Sales in Europe - Dr Paul Schober, General Manager, Peptech Animal Health; Boardroomradio is pleased to announce that Peptech (ASX: PTD) has published an audio file.
54,030 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 21) (Last 30 Days: 92) (Since Published: 13216)